Evidence map›Paper›PMID 29769147›Full record

ArticleParticle and fibre toxicology2018

Association of pulmonary, cardiovascular, and hematologic metrics with carbon nanotube and nanofiber exposure among U.S. workers: a cross-sectional study.

Mary K Schubauer-Berigan, Matthew M Dahm, Aaron Erdely, John D Beard, M Eileen Birch, Douglas E Evans, Joseph E Fernback, Robert R Mercer, Stephen J Bertke, Tracy Eye and 1 more

Open access · goldAbstract read
In one paragraph

Article in Particle and fibre toxicology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Adverse effects of nanoparticles on humans.Journal of occupational health · 2025
    Article
  4. Adverse effects of nanoparticles on humans.Journal of occupational health · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Mary K Schubauer-BeriganNational Institute for Occupational Safety and Health (NIOSH), Division of Surveillance, Hazard Evaluations, and Field Studies, 1090 Tusculum Ave MS-R15, Cincinnati, OH, 45226, USA. zcg3@cdc.gov.
Matthew M DahmNational Institute for Occupational Safety and Health (NIOSH), Division of Surveillance, Hazard Evaluations, and Field Studies, 1090 Tusculum Ave MS-R15, Cincinnati, OH, 45226, USA.
Aaron ErdelyNIOSH, Health Effects Laboratory Division, Morgantown, WV, USA.
John D BeardNational Institute for Occupational Safety and Health (NIOSH), Division of Surveillance, Hazard Evaluations, and Field Studies, 1090 Tusculum Ave MS-R15, Cincinnati, OH, 45226, USA.
M Eileen BirchNIOSH, Division of Applied Research and Technology, Cincinnati, OH, USA.
Douglas E EvansNIOSH, Division of Applied Research and Technology, Cincinnati, OH, USA.
Joseph E FernbackNIOSH, Division of Applied Research and Technology, Cincinnati, OH, USA.
Robert R MercerNIOSH, Health Effects Laboratory Division, Morgantown, WV, USA.
Stephen J BertkeNational Institute for Occupational Safety and Health (NIOSH), Division of Surveillance, Hazard Evaluations, and Field Studies, 1090 Tusculum Ave MS-R15, Cincinnati, OH, 45226, USA.
Tracy EyeNIOSH, Health Effects Laboratory Division, Morgantown, WV, USA.
Marie A de PerioNational Institute for Occupational Safety and Health (NIOSH), Division of Surveillance, Hazard Evaluations, and Field Studies, 1090 Tusculum Ave MS-R15, Cincinnati, OH, 45226, USA.
National Institute for Occupational Safety and Health · USEpidemic Intelligence Service · US

Funding

NIEHS NIH HHS Interagency Agreement AES 12029-001
6 · The paper itself

Abstract

backgroundCommercial use of carbon nanotubes and nanofibers (CNT/F) in composites and electronics is increasing; however, little is known about health effects among workers. We conducted a cross-sectional study among 108 workers at 12 U.S. CNT/F facilities. We evaluated chest symptoms or respiratory allergies since starting work with CNT/F, lung function, resting blood pressure (BP), resting heart rate (RHR), and complete blood count (CBC) components.

methodsWe conducted multi-day, full-shift sampling to measure background-corrected elemental carbon (EC) and CNT/F structure count concentrations, and collected induced sputum to measure CNT/F in the respiratory tract. We measured (nonspecific) fine and ultrafine particulate matter mass and count concentrations. Concurrently, we conducted physical examinations, BP measurement, and spirometry, and collected whole blood. We evaluated associations between exposures and health measures, adjusting for confounders related to lifestyle and other occupational exposures.

resultsCNT/F air concentrations were generally low, while 18% of participants had evidence of CNT/F in sputum. Respiratory allergy development was positively associated with inhalable EC (p=0.040) and number of years worked with CNT/F (p=0.008). No exposures were associated with spirometry-based metrics or pulmonary symptoms, nor were CNT/F-specific metrics related to BP or most CBC components. Systolic BP was positively associated with fine particulate matter (p-values: 0.015-0.054). RHR was positively associated with EC, at both the respirable (p=0.0074) and inhalable (p=0.0026) size fractions. Hematocrit was positively associated with the log of CNT/F structure counts (p=0.043).

conclusionsMost health measures were not associated with CNT/F. The positive associations between CNT/F exposure and respiratory allergies, RHR, and hematocrit counts may not be causal and require examination in other studies.

Indexed as

AdultAgedAir Pollutants, OccupationalBiomarkersBlood Cell CountCardiovascular SystemCross-Sectional StudiesFemaleHumansLeukocytesMaleMiddle AgedNanofibersNanotubes, CarbonOccupational ExposureRespiratory Function TestsAir Pollutants, OccupationalBiomarkersNanotubes, CarbonAdvanced manufacturingBlood pressureEpidemiologyHeart rateNanomaterialsNanotoxicologyOccupationalPulmonary function

Identifiers

PMID29769147
PMCPMC5956815
OpenAlexW2807531409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.